课题基金 / 基金详情

TRANSDERMAL ADJUVANT ADMINISTRATION OF PEPTIDE-BASED VACCINE, HIGH-RISK MELANOMA

TRANSDERMAL ADJUVANT ADMINISTRATION OF PEPTIDE-BASED VACCINE, HIGH-RISK MELANOMA
肽疫苗的透皮辅助给药,高风险黑色素瘤
批准号:
7606692
负责人:
Craig Lee Slingluff
金额:
$2.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-03-01 至 2008-02-29

项目摘要

项目成果

Craig Lee Slingluff的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will evaluate the safety and immunogenicity of twelve class I MHC-restricted melanoma-associated peptides when administered transdermally in different adjuvants to patients with advanced melanoma. As secondary endpoints, we will evaluate the recruitment and maturation of Langerhans cells in the skin and measure changes in serum cytokine levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Antibodies to melanoma vaccine peptides
  • 批准号:
    9378813
  • 项目类别:
  • 资助金额:
    $8.05万
  • 财政年份:
    2017
  • 负责人:
    Craig Lee Slingluff
  • 依托单位:
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
  • 批准号:
    9295843
  • 项目类别:
  • 资助金额:
    $39.48万
  • 财政年份:
    2013
  • 负责人:
    Craig Lee Slingluff
  • 依托单位:
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
  • 批准号:
    8692713
  • 项目类别:
  • 资助金额:
    $38.94万
  • 财政年份:
    2013
  • 负责人:
    Craig Lee Slingluff
  • 依托单位:
MELANOMA VACCINE FOR HELPER T CELLS COMBINED WITH TARGETED OR IMMUNE THERAPIES
  • 批准号:
    8561255
  • 项目类别:
  • 资助金额:
    $40.14万
  • 财政年份:
    2013
  • 负责人:
    Craig Lee Slingluff
  • 依托单位: